Mccowan Ronald M D Clinical Investigator is categorized under Doctors in Charleston, WV and active since 2010.
Mccowan Ronald M D Clinical Investigator was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 3100 Maccorkle Avenue Se # 806, Charleston, West Virginia WV 25304 or by phoning (304) 388-9937. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mccowan Ronald M D Clinical Investigator |
| Address: | 3100 Maccorkle Avenue Se # 806, Charleston, West Virginia 25304 |
| Phone Number: | (304) 388-9937 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Mccowan Ronald M D Clinical Investigator was started in 2010 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact for inquiries that concern Mccowan Ronald M D Clinical Investigator by calling the company number (304) 388-9937, as your correspondence is most welcome. Additionally, the physical location of the single location of Mccowan Ronald M D Clinical Investigator can be found at the coordinates 38.329537,-81.60851 as well as the street address 3100 Maccorkle Avenue Se # 806 in Charleston, West Virginia 25304.
For its online presence, you may visit Mccowan Ronald M D Clinical Investigator’s website at and engage with its social media outlets through on Twitter and on Facebook.